MedPath

Niacin

Niacin Tablets, USP 500 mg

Approved
Approval ID

f51f7e6d-b132-48d8-8bb1-54203472f0d8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 23, 2021

Manufacturers
FDA

Redmont Pharmaceuticals, LLC

DUNS: 080843607

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Niacin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code71741-020
Application NumberANDA040378
Product Classification
M
Marketing Category
C73584
G
Generic Name
Niacin
Product Specifications
Route of AdministrationORAL
Effective DateDecember 23, 2021
FDA Product Classification

INGREDIENTS (5)

HYDROGENATED SOYBEAN OILInactive
Code: A2M91M918C
Classification: IACT
NiacinActive
Quantity: 500 mg in 1 1
Code: 2679MF687A
Classification: ACTIB
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Niacin - FDA Drug Approval Details